Human melanoma cells inhibit the earliest differentiation steps of human Langerhans cell precursors but failed to affect the functional maturation of epidermal Langerhans cells
暂无分享,去创建一个
O. Berthier‐Vergnes | D. Schmitt | M. Staquet | J. Péguet-Navarro | M. Gaucherand | J. Plouet | J. Pageaux
[1] S. Imamura,et al. CD 34 + Hematopoietic Progenitors from Human Cord Blood Differentiate Along Two Independent Dendritic Cell Pathways in Response to GM-CSF + TNFoL , 2003 .
[2] G. Shurin,et al. Human Small Cell Lung Carcinoma and Carcinoid Tumor Regulate Dendritic Cell Maturation and Function , 2001, Modern Pathology.
[3] M. Lotze,et al. Neuroblastoma-derived gangliosides inhibit dendritic cell generation and function. , 2001, Cancer research.
[4] A. Cochran,et al. Penetration of human metastatic melanoma cells through an authentic dermal-epidermal junction is associated with dissolution of native collagen types IV and VII , 2000, Melanoma research.
[5] D. Schmitt,et al. Transforming growth factor‐β1 and ultraviolet A1 radiation increase production of vascular endothelial growth factor but not endothelin‐1 in human dermal fibroblasts , 2000 .
[6] M. Lotze,et al. Cytokine-mediated protection of human dendritic cells from prostate cancer-induced apoptosis is regulated by the Bcl-2 family of proteins , 2000, British Journal of Cancer.
[7] C. Caux,et al. Respective involvement of TGF‐β and IL‐4 in the development of Langerhans cells and non‐Langerhans dendritic cells from CD34+ progenitors , 1999, Journal of leukocyte biology.
[8] E. Kriehuber,et al. CD34+ cell-derived CD14+ precursor cells develop into Langerhans cells in a TGF-beta 1-dependent manner. , 1999, Journal of immunology.
[9] Simon C Watkins,et al. Tumor's other immune targets: dendritic cells , 1999, Journal of leukocyte biology.
[10] J. Blay,et al. Inhibition of the differentiation of dendritic cells from CD34(+) progenitors by tumor cells: role of interleukin-6 and macrophage colony-stimulating factor. , 1998, Blood.
[11] D. Carbone,et al. Defective function of Langerhans cells in tumor-bearing animals is the result of defective maturation from hemopoietic progenitors. , 1998, Journal of immunology.
[12] R. Steinman,et al. Dendritic cells and the control of immunity , 1998, Nature.
[13] A. Enk,et al. Induction of tolerance by IL-10-treated dendritic cells. , 1997, Journal of immunology.
[14] A. Enk,et al. Dendritic cells as mediators of tumor‐induced tolerance in metastatic melanoma , 1997, International journal of cancer.
[15] D. Hart,et al. Dendritic cells: unique leukocyte populations which control the primary immune response. , 1997, Blood.
[16] O. Majdic,et al. TGF-beta 1 promotes in vitro generation of dendritic cells by protecting progenitor cells from apoptosis. , 1997, Journal of immunology.
[17] D. Carbone,et al. Production of vascular endothelial growth factor by human tumors inhibits the functional maturation of dendritic cells , 1996, Nature Medicine.
[18] O. Majdic,et al. TGF-beta 1 promotes in vitro development of dendritic cells from CD34+ hemopoietic progenitors. , 1996, Journal of immunology.
[19] J. Banchereau,et al. CD34+ hematopoietic progenitors from human cord blood differentiate along two independent dendritic cell pathways in response to GM-CSF+TNF alpha , 1996, The Journal of experimental medicine.
[20] D. Strunk,et al. Generation of human dendritic cells/Langerhans cells from circulating CD34+ hematopoietic progenitor cells. , 1996, Blood.
[21] J. Banchereau,et al. Functional expression of CD40 antigen on human epidermal Langerhans cells. , 1995, Journal of immunology.
[22] K. Dutt,et al. Vasculotropin/Vascular endothelial growth factor is an autocrine growth factor for human retinal pigment epithelial cells cultued in vitro , 1995, Journal of cellular physiology.
[23] O. Berthier‐Vergnes,et al. Deficiency of ganglioside biosynthesis in metastatic human melanoma cells: relevance of CMP‐NeuAc: LacCer α2‐3 sialyltransferase (GM3 synthase) , 1995, FEBS letters.
[24] J. Banchereau,et al. Interleukin 10 inhibits T cell alloreaction induced by human dendritic cells. , 1994, International Immunology.
[25] J. Banchereau,et al. Interleukin‐10 inhibits the primary allogeneic T cell response to human epidermal Langerhans cells , 1994, European journal of immunology.
[26] O. Berthier‐Vergnes,et al. Expression of PNA‐binding sites on specific glycoproteins by human melanoma cells is associated with a high metastatic potential , 1994, Journal of cellular biochemistry.
[27] A. Cochran,et al. Expression of peanut agglutinin-binding glycoconjugates in primary melanomas with high risk of metastases , 1993, The Lancet.
[28] A. Cochran,et al. Variations in the distribution, frequency, and phenotype of Langerhans cells during the evolution of malignant melanoma of the skin. , 1993, The Journal of investigative dermatology.
[29] J. Banchereau,et al. GM-CSF and TNF-α cooperate in the generation of dendritic Langerhans cells , 1992, Nature.
[30] J. Tikerpae,et al. Interactions of tumor necrosis factor with granulocyte-macrophage colony-stimulating factor and other cytokines in the regulation of dendritic cell growth in vitro from early bipotent CD34+ progenitors in human bone marrow. , 1992, Journal of immunology.
[31] A. Cochran,et al. Quantitative alterations in cutaneous Langerhans cells during the evolution of malignant melanoma of the skin. , 1988, The Journal of investigative dermatology.